<!DOCTYPE html>
<html lang="en" dir="auto">

<head><script src="/livereload.js?mindelay=10&amp;v=2&amp;port=1313&amp;path=livereload" data-no-instant defer></script><meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="noindex, nofollow">
<title>Research Corruption | Behaviorism and Mental Health</title>
<meta name="keywords" content="">
<meta name="description" content="Alternative perspective on psychiatry&#39;s so-called mental disorders | PHILIP HICKEY, PH.D.">
<meta name="author" content="">
<link rel="canonical" href="http://localhost:1313/categories/research-corruption/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.2211ca3164be7830024f6aad2b3a2e520843a64f8f048445c3401c1249aa051d.css" integrity="sha256-IhHKMWS&#43;eDACT2qtKzouUghDpk&#43;PBIRFw0AcEkmqBR0=" rel="preload stylesheet" as="style">
<link rel="icon" href="http://localhost:1313/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="http://localhost:1313/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="http://localhost:1313/favicon-32x32.png">
<link rel="apple-touch-icon" href="http://localhost:1313/apple-touch-icon.png">
<link rel="mask-icon" href="http://localhost:1313/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<link rel="alternate" type="application/rss+xml" href="http://localhost:1313/categories/research-corruption/index.xml">
<link rel="alternate" hreflang="en" href="http://localhost:1313/categories/research-corruption/">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --code-block-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript>
</head>

<body class="list" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="http://localhost:1313/" accesskey="h" title="Behaviorism and Mental Health (Alt + H)">Behaviorism and Mental Health</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)" aria-label="Toggle theme">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
            <li>
                <a href="http://localhost:1313/categories/" title="Categories">
                    <span>Categories</span>
                </a>
            </li>
        </ul>
    </nav>
</header>
<main class="main"> 
<header class="page-header">
  <h1>
    Research Corruption
  </h1>
</header>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">Pharma Responds:  Antidepressants Really Work.  Really?
    </h2>
  </header>
  <div class="entry-content">
    <p>On July 25, 2017, Fredrik Hieronymus et al published a meta-analysis in Molecular Psychiatry. The study is titled Efficacy of selective serotonin reuptake inhibitors in the absence of side effects: a mega-analysis of citalopram and paroxetine in adult depression. Elias Eriksson, PhD, Head of the Department of Pharmacology, University of Gothenburg, Sweden, is the principal author, but as Fredrik Hieronymus is the first author listed, I will refer to the article as Hieronymus et al.
...</p>
  </div>
  <footer class="entry-footer"><span title='2017-09-07 05:30:40 +0000 UTC'>September 7, 2017</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to Pharma Responds:  Antidepressants Really Work.  Really?" href="http://localhost:1313/posts/pharma-responds-antidepressants-really-work-really/"></a>
</article>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">The FDA:  The Fox Guards the Hen House
    </h2>
  </header>
  <div class="entry-content">
    <p>In their Fall 2013 issue, the Journal of Law, Medicine, and Ethics published a symposium of papers by members of the Harvard’s Edmond J. Safra Center for Ethics. The symposium was called Institutional Corruption and Pharmaceutical Policy.
The symposium focuses on pharmaceutical products generally, but all the material is relevant and important in the context of psychiatric drugs.
In this post I will highlight one of these papers: Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs, by Donald W. Light, Joel Lexchin, and Jonathan J. Darrow.
...</p>
  </div>
  <footer class="entry-footer"><span title='2014-05-07 05:58:15 +0000 UTC'>May 7, 2014</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to The FDA:  The Fox Guards the Hen House" href="http://localhost:1313/posts/the-fda-the-fox-guards-the-hen-house/"></a>
</article>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">Sluggish Cognitive Tempo - A New Diagnosis?
    </h2>
  </header>
  <div class="entry-content">
    <p>On April 11, 2014, journalist Alan Schwarz (brief bio here) published an article in the New York Times on this topic, titled Idea of New attention Disorder Spurs Research, and Debate. Alan has written extensively on the rising rates of the condition known as ADHD, and on the abuse of the drugs that are used to “treat” this condition. He has drawn a good deal of criticism from psychiatry’s believers.
...</p>
  </div>
  <footer class="entry-footer"><span title='2014-04-29 05:58:20 +0000 UTC'>April 29, 2014</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to Sluggish Cognitive Tempo - A New Diagnosis?" href="http://localhost:1313/posts/sluggish-cognitive-tempo---a-new-diagnosis/"></a>
</article>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">Revitalizing Psychiatric Therapeutics?
    </h2>
  </header>
  <div class="entry-content">
    <p>In January of this year, Steven Hyman MD, former Director of NIMH and currently a leading psychiatric researcher at MIT and Harvard, published Revitalizing Psychiatric Therapeutics in Neuropsychopharmacology. The article is in the journal’s commentary section and is essentially an opinion piece. Here’s Dr. Hyman’s summary:
&#34;Despite high prevalence and enormous unmet medical need, the pharmaceutical industry has recently de-emphasized neuropsychiatric disorders as &#39;too difficult&#39; a challenge to warrant major investment. Here I describe major obstacles to drug discovery and development including a lack of new molecular targets, shortcomings of current animal models, and the lack of biomarkers for clinical trials. My major focus, however, is on new technologies and scientific approaches to neuropsychiatric disorders that give promise for revitalizing therapeutics and may thus answer industry&#39;s concerns.&#34;
...</p>
  </div>
  <footer class="entry-footer"><span title='2014-02-10 05:57:15 +0000 UTC'>February 10, 2014</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to Revitalizing Psychiatric Therapeutics?" href="http://localhost:1313/posts/revitalizing-psychiatric-therapeutics/"></a>
</article>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">CAFÉ Study: Real Science or Marketing Exercise?
    </h2>
  </header>
  <div class="entry-content">
    <p>BACKGROUND
On December 8, I received the following question from a reader: (The subject matter is the controversial CAFÉ – Comparisons of Atypicals in First Episode of Psychosis - study. This was the study in which Dan Markingson committed suicide.)
&#34;It appears that there was no head-to-head with a control group taking a placebo pill. Nor was there a control group featuring &#39;old&#39; types of &#39;antipsychotic&#39;. If that was the case then it is very poor study. If you are just looking at 3 &#39;new&#39; subtypes of a &#39;new&#39; class - then what on earth can you hope to show from the data.&#34;
...</p>
  </div>
  <footer class="entry-footer"><span title='2013-12-18 05:58:21 +0000 UTC'>December 18, 2013</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to CAFÉ Study: Real Science or Marketing Exercise?" href="http://localhost:1313/posts/caf%C3%A9-study-real-science-or-marketing-exercise/"></a>
</article>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">U of Minnesota Faculty Senate Vote To Review Dan Markingson&#39;s Death
    </h2>
  </header>
  <div class="entry-content">
    <p>In 2004, 26-year-old Dan Markingson committed suicide. Since then, numerous concerns have been expressed about the events that led up to his death. In particular, it has been claimed that he was coerced into the CAFE study, and that he was too delusional to understand what was involved. It has also been reported widely that his mother, Mary Weiss, saw his condition deteriorate while he was taking the study drug - Seroquel (quetiapine) - and that she made numerous unsuccessful requests to the researchers to have him removed from the study.
...</p>
  </div>
  <footer class="entry-footer"><span title='2013-12-06 10:39:03 +0000 UTC'>December 6, 2013</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to U of Minnesota Faculty Senate Vote To Review Dan Markingson&#39;s Death" href="http://localhost:1313/posts/u-of-minnesota-faculty-senate-vote-to-review-dan-markingson-s-death/"></a>
</article>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">Neuroleptics for Children: Harvard&#39;s Shame
    </h2>
  </header>
  <div class="entry-content">
    <p>In December 2012, Mark Olfson, MD, et al, published an article in the Archives of General Psychiatry. The title is National Trends in the Office-Based Treatment of Children, Adolescents, and Adults with Antipsychotics. The authors collected data from the National Ambulatory Medical Care Surveys for the period 1993-2009, and looked for trends in antipsychotic prescribing for children, adolescents, and adults in outpatient visits. Here are the results:
Age Increase in no. of antipsychotic prescriptions per 100 population (1993-2009) 0-13 0.24-1.83 (almost 8-fold) 14-20 0.78-3.76 (almost 5-fold) 21&#43; 3.25-6.18 (almost 2-fold)   The authors provide a breakdown of the diagnoses assigned to the children and adolescents during the antipsychotic visits.
...</p>
  </div>
  <footer class="entry-footer"><span title='2013-12-04 05:58:42 +0000 UTC'>December 4, 2013</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to Neuroleptics for Children: Harvard&#39;s Shame" href="http://localhost:1313/posts/neuroleptics-for-children-harvard-s-shame/"></a>
</article>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">Jon Rappoport&#39;s Blog
    </h2>
  </header>
  <div class="entry-content">
    <p>If you haven’t seen Jon Rappoport’s blog, please take a look. Here are two quotes from his September 22 post, Psychiatry targets college students for destruction:
&#34;The concept called &#39;mental disorder&#39; is a sales pitch backed up by extraordinary PR, money, academic gibberish, and government-granted official status.&#34;
&#34;People need to wake up to the fact that the whole panoply of human suffering has been co-opted, taken over, redefined, re-translated into a lexicon of pseudoscience.&#34;
...</p>
  </div>
  <footer class="entry-footer"><span title='2013-09-30 05:37:53 +0000 UTC'>September 30, 2013</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to Jon Rappoport&#39;s Blog" href="http://localhost:1313/posts/jon-rappoport-s-blog/"></a>
</article>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">Pharma Mobilizing Consumer Groups Over Drug Trials Data
    </h2>
  </header>
  <div class="entry-content">
    <p>There was an interesting article Big pharma mobilising patients in battle over drugs trials data in last Sunday’s Guardian, a UK newspaper. It was written by Ian Sample, the Guardian’s science correspondent. Here are the two opening sentences:
&#34;The pharmaceutical industry has &#39;mobilised&#39; an army of patient groups to lobby against plans to force companies to publish secret documents on drugs trials.&#34;
&#34;Drugs companies publish only a fraction of their results and keep much of the information to themselves, but regulators want to ban the practice. If companies published all of their clinical trials data, independent scientists could reanalyse their results and check companies&#39; claims about the safety and efficacy of drugs.&#34;
...</p>
  </div>
  <footer class="entry-footer"><span title='2013-07-26 09:02:01 +0000 UTC'>July 26, 2013</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to Pharma Mobilizing Consumer Groups Over Drug Trials Data" href="http://localhost:1313/posts/pharma-mobilizing-consumer-groups-over-drug-trials-data/"></a>
</article>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">The CAFE Study: Dr. Lieberman&#39;s High Moral Ground
    </h2>
  </header>
  <div class="entry-content">
    <p>BACKGROUND
The CAFE Study, conducted by Jeffrey Lieberman, MD, et al between 2002 and 2005, has been the subject of much comment. Carl Elliott, in particular, has written extensively on the matter, including his article The Deadly Corruption of Clinical Trials in Mother Jones.
In order to address the issues involved in the CAFE study, we must first take a brief look at the CATIE study. This was also conducted by Dr. Lieberman et al (not the same et al as CAFE, but with some overlap). CATIE was conducted between 2001 and 2004.
...</p>
  </div>
  <footer class="entry-footer"><span title='2013-07-16 06:10:55 +0000 UTC'>July 16, 2013</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to The CAFE Study: Dr. Lieberman&#39;s High Moral Ground" href="http://localhost:1313/posts/the-cafe-study-dr-lieberman-s-high-moral-ground/"></a>
</article>
<footer class="page-footer">
  <nav class="pagination">
    <a class="next" href="http://localhost:1313/categories/research-corruption/page/2/">Next&nbsp;&nbsp;»
    </a>
  </nav>
</footer>
    </main>
    
<footer class="footer">
        <span>&copy; 2025 <a href="http://localhost:1313/">Behaviorism and Mental Health</a></span> · 

    <span>
        Powered by
        <a href="https://gohugo.io/" rel="noopener noreferrer" target="_blank">Hugo</a> &
        <a href="https://github.com/adityatelange/hugo-PaperMod/" rel="noopener" target="_blank">PaperMod</a>
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
